Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients

NCT04428008 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Thymalfasin

Sponsor

William B. Ershler, MD

Collaborators

[object Object]